FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss
 

Today, the U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.

More...